《大行》大摩:药明康德(02359.HK)获批出初步禁制令 解除1260H清单不明朗因素

阿斯达克财经
Aug 10

摩根士丹利发表研究报告指,药明康德(02359.HK) 公布就美国国防部将公司列入“第1260H条”清单,今年6月底向美国哥伦比亚特区地区法院申请初步禁制令,有关禁制令于日前获批,即时解除被列入1260H清单所带来的负面影响。报告指,美国哥伦比亚特区地区法院首席法官James Boasberg表示,美国当局有关药明康德间接由中国国资委、国防科工局及解放军拥有或关联的指控可能理据不足,其所有权认定...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10